Dr Zaklina Kovacevic

Dr Zaklina Kovacevic

Senior Lecturer

Bachelor of Medical Sciences (Honours Class 1), University of Sydney - 2006

PhD (Medicine), University of Sydney - 2011

Medicine & Health
School of Biomedical Sciences

Dr. Kovacevic completed her PhD in 2011 at the University of Sydney, where she also undertook her post-doctoral studies, being supported by joint NHMRC and CINSW Early Career and Career Development Fellowships. Her PhD studies focused on developing a new class of metal-binding thiosemicarbazones as anti-cancer agents and elucidating their molecular mechanisms in numerous cancer types including pancreatic, prostate and breast cancers. This work facilitated the entry of lead agent, DpC, into Australian multi-centre clinical trials in 2016. She also made significant contributions to understanding the function of the iron-regulated metastasis suppressor N-myc down-stream regulated gene 1 (NDRG1), identifying the important role of this protein in cancer progression, development of resistance to chemotherapies and cross-talk with the tumour microenvironment. 

In 2020 Dr. Kovacevic established her independent research group at the University of Sydney, and in 2023 she relocated to UNSW where she now heads to Tumour Microenvironment group within the School of Biomedical Sciences. Her research is focused on understanding the cross-talk between cancer cells and the tumour microenvironment, with a particular interest in pancreatic cancer. She has published 81 research outputs (>5500 citations) and attracted >$8.5 million in research grants/fellowships ($3 million as lead investigator). Her research achievements were recognized by the 2016 Premier's Award for Outstanding Cancer Research Fellow of the Year and the 2016 Sydney Medical School Award for Excellence for Outstanding Early Career Researcher. 

Over her career, Dr. Kovacevic has co-supervised and mentored 30 postgraduate students (PhD/Masters/Honours) to successful completion, including 6 as primary supervisor. Her team currently consists of 3 PhD and 1 Honours students. Dr. Kovacevic is also actively involved in peer review, being an Editorial Board Member for 7 international journals (i.e. Biochem. J, BBA Gen Subjects, Pharmacol. Res, etc.) and is regularly involved in grant assessment for national and international funding bodies (i.e. NHMRC, National Breast Cancer Foundation). As a Senior Lecturer in the Department of Physiology, Dr. Kovacevic is also integrally involved in teaching into undergraduate Medicine and Physiology units at UNSW.

Location
Level 4E Wallace Wurth Building C27 University of NSW Team website: http://unsw.to/tme-lab
  • Journal articles | 2026
    Chang J; Alenizi S; Milioli HZ; Lay W; Pounraj S; Li Y; Shiferaw MS; Hosseini-Beheshti E; Kovacevic Z, 2026, 'Silencing the Signal: The Metastasis Suppressor NDRG1 Disrupts Small Extracellular Vesicle-Mediated Crosstalk in Pancreatic Cancer', Journal of Extracellular Vesicles, 15, http://dx.doi.org/10.1002/jev2.70334
    Journal articles | 2026
    Shiferaw MS; Somers K; Kovacevic Z, 2026, 'MYCN-driven metabolic remodelling of the tumour microenvironment in neuroblastoma: implications for stromal biology and CAF heterogeneity', Cancer and Metastasis Reviews, 45, http://dx.doi.org/10.1007/s10555-026-10355-w
    Journal articles | 2023
    Chang J; Lo ZHY; Alenizi S; Kovacevic Z, 2023, 'Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1', Cancers, 15, http://dx.doi.org/10.3390/cancers15102779
    Journal articles | 2023
    Shehadeh-Tout F; Milioli HH; Roslan S; Jansson PJ; Dharmasivam M; Graham D; Anderson R; Wijesinghe T; Azad MG; Richardson DR; Kovacevic Z, 2023, 'Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer', Pharmacological Research, 193, http://dx.doi.org/10.1016/j.phrs.2023.106806
    Journal articles | 2022
    Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovacevic Z, 2022, 'Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1', Journal of Biological Chemistry, 298, http://dx.doi.org/10.1016/j.jbc.2022.101608
    Journal articles | 2021
    Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Kovacevic Z; Richardson DR; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M, 2021, 'Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression (Breast Cancer Research, (2020), 22, 1, (75), 10.1186/s13058-020-01312-8)', Breast Cancer Research, 23, http://dx.doi.org/10.1186/s13058-020-01383-7
    Journal articles | 2021
    Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z, 2021, 'Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma', FASEB Journal, 35, http://dx.doi.org/10.1096/fj.202002279R
    Journal articles | 2021
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž, 2021, 'The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer', Journal of Biological Chemistry, 297, http://dx.doi.org/10.1016/j.jbc.2021.101414
    Journal articles | 2020
    Fouani L; Huang MLH; Cole L; Jansson PJ; Kovacevic Z; Richardson DR, 2020, 'During mitosis ZEB1 “switches” from being a chromatin-bound epithelial gene repressor, to become a microtubule-associated protein', Biochimica Et Biophysica Acta Molecular Cell Research, 1867, http://dx.doi.org/10.1016/j.bbamcr.2020.118673
    Journal articles | 2020
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z, 2020, 'Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance', FASEB Journal, 34, pp. 11511 - 11528, http://dx.doi.org/10.1096/fj.201903167R
    Journal articles | 2020
    Maqbool SN; Lim SC; Park KC; Hanif R; Richardson DR; Jansson PJ; Kovacevic Z, 2020, 'Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC', British Journal of Pharmacology, 177, pp. 2365 - 2380, http://dx.doi.org/10.1111/bph.14985
    Journal articles | 2020
    Park KC; Geleta B; Leck LYW; Paluncic J; Chiang S; Jansson PJ; Kovacevic Z; Richardson DR, 2020, 'Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding', Journal of Biological Chemistry, 295, pp. 481 - 503, http://dx.doi.org/10.1074/jbc.RA119.011341
    Journal articles | 2020
    Park KC; Paluncic J; Kovacevic Z; Richardson DR, 2020, 'Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer', Free Radical Biology and Medicine, 157, pp. 154 - 175, http://dx.doi.org/10.1016/j.freeradbiomed.2019.05.020
    Journal articles | 2019
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR, 2019, 'Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes', Inorganic Chemistry, 58, pp. 13709 - 13723, http://dx.doi.org/10.1021/acs.inorgchem.9b01281
    Journal articles | 2019
    Fouani L; Kovacevic Z; Richardson DR, 2019, 'Targeting oncogenic nuclear factor kappa B signaling with redox-active agents for cancer treatment', Antioxidants and Redox Signaling, 30, pp. 1096 - 1123, http://dx.doi.org/10.1089/ars.2017.7387
    Journal articles | 2019
    Gamell C; Bandilovska I; Gulati T; Kogan A; Lim SC; Kovacevic Z; Takano EA; Timpone C; Agupitan AD; Litchfield C; Blandino G; Horvath LG; Fox SB; Williams SG; Russo A; Gallo E; Paul PJ; Mitchell C; Sandhu S; Keam SP; Haupt S; Richardson DR; Haupt Y, 2019, 'E6AP Promotes a Metastatic Phenotype in Prostate Cancer', Iscience, 22, pp. 1 - 15, http://dx.doi.org/10.1016/j.isci.2019.10.065
    Journal articles | 2019
    Menezes SV; Kovacevic Z; Richardson DR, 2019, 'Erratum: The metastasis suppressor NRDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6 (Journal of Biological Chemistry (2019) 294 (4045–4064)DOI: 10.1074/jbc.RA118.006279', Journal of Biological Chemistry, 294, pp. 11675, http://dx.doi.org/10.1074/jbc.AAC119.010021
    Journal articles | 2019
    Menezes SV; Kovacevic Z; Richardson DR, 2019, 'The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6', Journal of Biological Chemistry, 294, pp. 4045 - 4064, http://dx.doi.org/10.1074/jbc.RA118.006279
    Journal articles | 2019
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang MLH; Lane DJR; Lok H; Richardson DR, 2019, 'Exploiting cancer metal metabolism using anti-cancer metal- binding agents', Current Medicinal Chemistry, 26, pp. 302 - 322, http://dx.doi.org/10.2174/0929867324666170705120809
    Journal articles | 2019
    Moussa RS; Park KC; Kovacevic Z; Richardson DR, 2019, 'Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity', Free Radical Biology and Medicine, 133, pp. 276 - 294, http://dx.doi.org/10.1016/j.freeradbiomed.2018.03.027
    Journal articles | 2019
    Sahni S; Park KC; Kovacevic Z; Richardson DR, 2019, 'Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1', Biochimica Et Biophysica Acta Molecular Basis of Disease, 1865, pp. 1361 - 1378, http://dx.doi.org/10.1016/j.bbadis.2019.02.008
    Journal articles | 2019
    Yunus M; Jansson PJ; Kovacevic Z; Kalinowski DS; Richardson DR, 2019, 'Tumor-induced neoangiogenesis and receptor tyrosine kinases – Mechanisms and strategies for acquired resistance', Biochimica Et Biophysica Acta General Subjects, 1863, pp. 1217 - 1225, http://dx.doi.org/10.1016/j.bbagen.2019.04.017
    Journal articles | 2018
    Menezes S; Fouani L; Huang M; Geleta B; Maleki S; Richardson A; Richardson D; Kovacevic Z, 2018, 'The Metastasis Suppressor, NDRG1 Attenuates Oncogenic TGF-β and NF-ĸB Signaling to Enhance Membrane E-Cadherin Expression in Pancreatic Cancer Cell', Carcinogenesis, http://dx.doi.org/10.1093/carcin/bgy178
    Journal articles | 2018
    Menezes S; Kovacevic Z; Richardson D, 2018, 'P-106 The redox-active thiosemicarbazone, Dp44mT promotes NDRG1 to down-regulate oncogenic signaling pathways in cancer', Free Radical Biology and Medicine, 120, pp. s76 - s77, http://dx.doi.org/10.1016/j.freeradbiomed.2018.04.253
    Journal articles | 2018
    Menezes SV; Kovacevic Z; Richardson D, 2018, 'Abstract A165: Novel thiosemicarbazone, Dp44mT, promotes NDRG1 to downregulate oncogenic signaling pathways in cancer', Molecular Cancer Therapeutics, 17, pp. a165 - a165, http://dx.doi.org/10.1158/1535-7163.targ-17-a165
    Journal articles | 2018
    Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR, 2018, 'Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT', Biochimica Et Biophysica Acta General Subjects, 1862, pp. 761 - 774, http://dx.doi.org/10.1016/j.bbagen.2017.10.009
    Journal articles | 2018
    Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR, 2018, 'Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1', Biochimica Et Biophysica Acta Molecular Basis of Disease, 1864, pp. 2644 - 2663, http://dx.doi.org/10.1016/j.bbadis.2018.04.011
    Journal articles | 2017
    Fouani L; Menezes SV; Paulson M; Richardson DR; Kovacevic Z, 2017, 'Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents', Pharmacological Research, 115, pp. 275 - 287, http://dx.doi.org/10.1016/j.phrs.2016.12.001
    Journal articles | 2017
    Kovacevic Z; Sahni S; Lok H; Davies MJ; Wink DA; Richardson DR, 2017, 'Regulation and control of nitric oxide (NO) in macrophages: Protecting the “professional killer cell” from its own cytotoxic arsenal via MRP1 and GSTP1', Biochimica Et Biophysica Acta General Subjects, 1861, pp. 995 - 999, http://dx.doi.org/10.1016/j.bbagen.2017.02.021
    Journal articles | 2017
    Menezes SV; Sahni S; Kovacevic Z; Richardson DR, 2017, 'Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling', Journal of Biological Chemistry, 292, pp. 12772 - 12782, http://dx.doi.org/10.1074/jbc.R117.776393
    Journal articles | 2017
    Xi R; Pun IHY; Menezes SV; Fouani L; Kalinowski DS; Huang MLH; Zhang X; Richardson DR; Kovacevic Z, 2017, 'Novel thiosemicarbazones inhibit lysine-rich carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) coisolated (LYRIC) and the LYRIC-induced epithelial-mesenchymal transition via upregulation of N-Myc downstream-regulated gene 1 (NDRG1)', Molecular Pharmacology, 91, pp. 499 - 517, http://dx.doi.org/10.1124/mol.116.107870
    Journal articles | 2016
    Al-Eisawi Z; Stefani C; Jansson PJ; Arvind A; Sharpe PC; Basha MT; Iskander GM; Kumar N; Kovacevic Z; Lane DJR; Sahni S; Bernhardt PV; Richardson DR; Kalinowski DS, 2016, 'Novel Mechanism of Cytotoxicity for the Selective Selenosemicarbazone, 2-Acetylpyridine 4,4-Dimethyl-3-selenosemicarbazone (Ap44mSe): Lysosomal Membrane Permeabilization', Journal of Medicinal Chemistry, 59, pp. 294 - 312, http://dx.doi.org/10.1021/acs.jmedchem.5b01399
    Journal articles | 2016
    Cahill MA; Jazayeri JA; Catalano SM; Toyokuni S; Kovacevic Z; Richardson DR, 2016, 'The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology', Biochimica Et Biophysica Acta Reviews on Cancer, 1866, pp. 339 - 349, http://dx.doi.org/10.1016/j.bbcan.2016.07.004
    Journal articles | 2016
    Cahill MA; Jazayeri JA; Kovacevic Z; Richardson DR, 2016, 'PGRMC1 regulation by phosphorylation: Potential new insights in controlling biological activity!', Oncotarget, 7, pp. 50822 - 50827, http://dx.doi.org/10.18632/oncotarget.10691
    Journal articles | 2016
    Chiang S; Kovacevic Z; Sahni S; Lane DJR; Merlot AM; Kalinowski DS; Huang MLH; Richardson DR, 2016, 'Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia', Clinical Science, 130, pp. 853 - 870, http://dx.doi.org/10.1042/CS20160072
    Journal articles | 2016
    Guo ZL; Richardson DR; Kalinowski DS; Kovacevic Z; Tan-Un KC; Chan GCF, 2016, 'The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0330-x
    Journal articles | 2016
    Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJR; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR, 2016, 'Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)', Biochimica Et Biophysica Acta Molecular Cell Research, 1863, pp. 1665 - 1681, http://dx.doi.org/10.1016/j.bbamcr.2016.04.017
    Journal articles | 2016
    Kalinowski DS; Stefani C; Toyokuni S; Ganz T; Anderson GJ; Subramaniam NV; Trinder D; Olynyk JK; Chua A; Jansson PJ; Sahni S; Lane DJR; Merlot AM; Kovacevic Z; Huang MLH; Lee CS; Richardson DR, 2016, 'Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics', Biochimica Et Biophysica Acta Molecular Cell Research, 1863, pp. 727 - 748, http://dx.doi.org/10.1016/j.bbamcr.2016.01.026
    Journal articles | 2016
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJR; Richardson DR, 2016, 'The metastasis suppressor, N-MYC downstream-regulated gene-1 (NDRG1), down-regulates the ErbB family of receptors to inhibit downstream oncogenic signaling pathways', Journal of Biological Chemistry, 291, pp. 1029 - 1052, http://dx.doi.org/10.1074/jbc.M115.689653
    Journal articles | 2016
    Kovacevic Z; Sahni S; Richardson DR, 2016, 'Copper that cancer with lysosomal love!', Aging, 8, pp. 210 - 211, http://dx.doi.org/10.18632/aging.100910
    Journal articles | 2016
    Lane DJR; Saletta F; Rahmanto YS; Kovacevic Z; Richardson DR, 2016, 'Correction: N-myc Downstream Regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0149922
    Journal articles | 2016
    Lok HC; Sahni S; Jansson PJ; Kovacevic Z; Hawkins CL; Richardson DR, 2016, 'A nitric oxide storage and transport system that protects activated macrophages from endogenous nitric oxide cytotoxicity', Journal of Biological Chemistry, 291, pp. 27042 - 27061, http://dx.doi.org/10.1074/jbc.M116.763714
    Journal articles | 2016
    Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR, 2016, 'Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase', Biochemical Pharmacology, 109, pp. 27 - 47, http://dx.doi.org/10.1016/j.bcp.2016.04.001
    Journal articles | 2016
    Paluncic J; Kovacevic Z; Jansson PJ; Kalinowski D; Merlot AM; Huang MLH; Lok HC; Sahni S; Lane DJR; Richardson DR, 2016, 'Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling', Biochimica Et Biophysica Acta Molecular Cell Research, 1863, pp. 770 - 784, http://dx.doi.org/10.1016/j.bbamcr.2016.01.025
    Journal articles | 2016
    Park KC; Fouani L; Jansson PJ; Wooi D; Sahni S; Lane DJR; Palanimuthu D; Lok HC; Kovačević Z; Huang MLH; Kalinowski DS; Richardson DR, 2016, 'Copper and conquer: Copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics', Metallomics, 8, pp. 874 - 886, http://dx.doi.org/10.1039/c6mt00105j
    Journal articles | 2016
    Sahni S; Kovacevic Z; Kalinowski DS; Huang M; Menezes S; Krishan S; Lane DJ; Jansson PJ; Richardson DR, 2016, 'Targeting autophagy in antitumor agent design: Furthering the 'lysosomal love' strategy', Future Medicinal Chemistry, 8, pp. 727 - 729, http://dx.doi.org/10.4155/fmc-2016-0066
    Journal articles | 2016
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang MLH; Zheng M; Kovacevic Z; Richardson DR, 2016, 'Targeting the metastasis suppressor, n-myc downstream regulated gene-1, with novel di-2-pyridylketone thiosemicarbazones: Suppression of tumor cell migration and cell-collagen adhesion by inhibiting focal adhesion kinase/paxillin signaling', Molecular Pharmacology, 89, pp. 521 - 540, http://dx.doi.org/10.1124/mol.115.103044
    Journal articles | 2015
    Jansson PJ; Kalinowski DS; Lane DJR; Kovacevic Z; Seebacher NA; Fouani L; Sahni S; Merlot AM; Richardson DR, 2015, 'The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazones', Pharmacological Research, 100, pp. 255 - 260, http://dx.doi.org/10.1016/j.phrs.2015.08.013
    Journal articles | 2015
    Liu W; Kovacevic Z; Peng Z; Jin R; Wang P; Yue F; Zheng M; Huang MLH; Jansson PJ; Richardson V; Kalinowski DS; Lane DJR; Merlot AM; Sahni S; Richardson DR, 2015, 'The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: New therapeutic targets', Oncotarget, 6, pp. 35522 - 35541, http://dx.doi.org/10.18632/oncotarget.5849
    Journal articles | 2015
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Liu G; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR, 2015, 'The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1', Oncotarget, 6, pp. 8851 - 8874, http://dx.doi.org/10.18632/oncotarget.3316
    Journal articles | 2015
    Lui GYL; Kovacevic Z; Menezes SV; Kalinowski DS; Merlot AM; Sahni S; Richardson DR, 2015, 'Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (stat3) pathway: Inhibition of constitutive and interleukin 6-induced activation by iron depletion', Molecular Pharmacology, 87, pp. 543 - 560, http://dx.doi.org/10.1124/mol.114.096529
    Journal articles | 2015
    Lui GYL; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR, 2015, 'Targeting cancer by binding iron: Dissecting cellular signaling pathways', Oncotarget, 6, pp. 18748 - 18779, http://dx.doi.org/10.18632/oncotarget.4349
    Journal articles | 2015
    Lui GYL; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR, 2015, 'Targeting cancer by binding iron: Dissecting cellular signaling pathways', Oncotarget, 6, pp. 18748 - 18779, http://dx.doi.org/10.18632/oncotarget.v6i22
    Journal articles | 2015
    Menezes SV; Kovacevic Z; Richardson DR, 2015, 'Abstract A63: Role of the metastasis suppressor, NDRG1, in regulating the EGFR and ErbB family of receptors and its effects on key oncogenic signaling pathways in pancreatic cancer', Molecular Cancer Therapeutics, 14, pp. a63 - a63, http://dx.doi.org/10.1158/1535-7163.targ-15-a63
    Journal articles | 2015
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Lane DJ; Huang MLH; Sahni S; Richardson DR, 2015, 'Making a case for albumin - A highly promising drug-delivery system', Future Medicinal Chemistry, 7, pp. 553 - 556, http://dx.doi.org/10.4155/fmc.15.15
    Journal articles | 2015
    Moussa RS; Kovacevic Z; Richardson DR, 2015, 'Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types', Oncotarget, 6, pp. 29694 - 29711, http://dx.doi.org/10.18632/oncotarget.5088
    Journal articles | 2015
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M, 2015, 'The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44', Oncotarget, 6, pp. 33893 - 33911, http://dx.doi.org/10.18632/oncotarget.5294
    Journal articles | 2014
    Fang BA; Kovačević Z; Park KC; Kalinowski DS; Jansson PJ; Lane DJR; Sahni S; Richardson DR, 2014, 'Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy', Biochimica Et Biophysica Acta Reviews on Cancer, 1845, pp. 1 - 19, http://dx.doi.org/10.1016/j.bbcan.2013.11.002
    Journal articles | 2014
    Jin R; Liu W; Menezes S; Yue F; Zheng M; Kovacevic Z; Richardson DR, 2014, 'The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of ß-catenin through mechanisms involving FRAT1 and PAK4', Journal of Cell Science, 127, pp. 3116 - 3130, http://dx.doi.org/10.1242/jcs.147835
    Journal articles | 2014
    Lane DJR; Mills TM; Shafie NH; Merlot AM; Saleh Moussa R; Kalinowski DS; Kovacevic Z; Richardson DR, 2014, 'Expanding horizons in iron chelation and the treatment of cancer: Role of iron in the regulation of ER stress and the epithelial-mesenchymal transition', Biochimica Et Biophysica Acta Reviews on Cancer, 1845, pp. 166 - 181, http://dx.doi.org/10.1016/j.bbcan.2014.01.005
    Journal articles | 2014
    Lok HC; Sahni S; Richardson V; Kalinowski DS; Kovacevic Z; Lane DJR; Richardson DR, 2014, 'Glutathione S-transferase and MRP1 form an integrated system involved in the storage and transport of dinitrosyl-dithiolato iron complexes in cells', Free Radical Biology and Medicine, 75, pp. 14 - 29, http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.002
    Journal articles | 2014
    Sahni S; Bae DH; Lane DJR; Kovacevic Z; Kalinowski DS; Jansson PJ; Richardson DR, 2014, 'The metastasis suppressor, N-myc Downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells', Journal of Biological Chemistry, 289, pp. 9692 - 9709, http://dx.doi.org/10.1074/jbc.M113.529511
    Journal articles | 2013
    Bae DH; Jansson PJ; Huang ML; Kovacevic Z; Kalinowski D; Lee CS; Sahni S; Richardson DR, 2013, 'The role of NDRG1 in the pathology and potential treatment of human cancers', Journal of Clinical Pathology, 66, pp. 911 - 917, http://dx.doi.org/10.1136/jclinpath-2013-201692
    Journal articles | 2013
    Dixon KM; Lui GYL; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR, 2013, 'Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells', British Journal of Cancer, 108, pp. 409 - 419, http://dx.doi.org/10.1038/bjc.2012.582
    Journal articles | 2013
    Kalinowski DS; Jansson PJ; Kovacevic Z; Richardson DR, 2013, 'The redox-active, anti-cancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism', Redox Report, 18, pp. 48 - 50, http://dx.doi.org/10.1179/1351000213Y.0000000041
    Journal articles | 2013
    Kovacevic Z; Chikhani S; Lui GYL; Sivagurunathan S; Richardson DR, 2013, 'The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and ras signaling pathways', Antioxidants and Redox Signaling, 18, pp. 874 - 887, http://dx.doi.org/10.1089/ars.2011.4273
    Journal articles | 2013
    Lane DJR; Saletta F; Rahmanto YS; Kovacevic Z; Richardson DR, 2013, 'N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion', Plos One, 8, http://dx.doi.org/10.1371/journal.pone.0057273
    Journal articles | 2013
    Lui GYL; Kovacevic Z; Richardson DR, 2013, 'Abstract A232: Novel thiosemicarbazones with potent antitumor and antimetastatic activity inhibit the signal transducer and activator of transcription (STAT) pathway.', Molecular Cancer Therapeutics, 12, pp. a232 - a232, http://dx.doi.org/10.1158/1535-7163.targ-13-a232
    Journal articles | 2013
    Lui GYL; Obeidy P; Ford SJ; Tselepis C; Sharp DM; Jansson PJ; Kalinowski DS; Kovacevic Z; Lovejoy DB; Richardson DR, 2013, 'The iron chelator, deferasirox, as a novel strategy for cancer treatment: Oral activity against human lung tumor xenografts and molecular mechanism of actions', Molecular Pharmacology, 83, pp. 179 - 190, http://dx.doi.org/10.1124/mol.112.081893
    Journal articles | 2013
    Richardson A; Kovacevic Z; Richardson DR, 2013, 'Iron chelation: Inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancreatic cancer and other tumors', Critical Reviews in Oncogenesis, 18, pp. 409 - 434, http://dx.doi.org/10.1615/CritRevOncog.2013007921
    Journal articles | 2013
    Sun J; Zhang D; Bae DH; Sahni S; Jansson P; Zheng Y; Zhao Q; Yue F; Zheng M; Kovacevic Z; Richardson DR, 2013, 'Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors', Carcinogenesis, 34, pp. 1943 - 1954, http://dx.doi.org/10.1093/carcin/bgt163
    Journal articles | 2013
    Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR, 2013, 'Targeting the metastasis suppressor, NDRG1, using novel iro chelators: Regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway', Molecular Pharmacology, 83, pp. 454 - 469, http://dx.doi.org/10.1124/mol.112.083097
    Journal articles | 2012
    Chen Z; Zhang D; Yue F; Zheng M; Kovacevic Z; Richardson DR, 2012, 'The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1)', Journal of Biological Chemistry, 287, pp. 17016 - 17028, http://dx.doi.org/10.1074/jbc.M112.350470
    Journal articles | 2012
    Correnti C; Richardson V; Sia AK; Bandaranayake AD; Ruiz M; Rahmanto YS; Kovačević Z; Clifton MC; Holmes MA; Kaiser BK; Barasch J; Raymond KN; Richardson DR; Strong RK, 2012, 'Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines', Plos One, 7, http://dx.doi.org/10.1371/journal.pone.0043696
    Journal articles | 2012
    Kovacevic Z, 2012, 'Targeting Iron in Cancer Cells: A New Strategy to Inhibit Metastatic Progression', Vitamins & Trace Elements, 01, http://dx.doi.org/10.4172/2167-0390.1000e114
    Journal articles | 2012
    Richardson DR; Chikhani S; Lui G; Sivagurunathan S; Kovacevic Z, 2012, 'Targeting the Metastasis Suppressor NDRG1: A New Strategy for the Treatment of Pancreatic Cancer', The FASEB Journal, 26, pp. 761.28 - 761.28, http://dx.doi.org/10.1096/fasebj.26.1_supplement.761.28
    Journal articles | 2012
    Saletta F; Kovacevic Z; Richardson DR, 2012, 'Erratum: Iron chelation: Deciphering novel molecular targets for cancer therapy. The tip of the iceberg of a web of iron-regulated molecules (Future Medicinal Chemistry (2011) 3:16 (1983-1986))', Future Medicinal Chemistry, 4, pp. 124, http://dx.doi.org/10.4155/fmc.11.178
    Journal articles | 2012
    Serda M; Kalinowski DS; Mrozek-Wilczkiewicz A; Musiol R; Szurko A; Ratuszna A; Pantarat N; Kovacevic Z; Merlot AM; Richardson DR; Polanski J, 2012, 'Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy', Bioorganic and Medicinal Chemistry Letters, 22, pp. 5527 - 5531, http://dx.doi.org/10.1016/j.bmcl.2012.07.030
    Journal articles | 2012
    Yu Y; Gutierrez E; Kovacevic Z; Saletta F; Obeidy P; Rahmanto YS; Richardson DR, 2012, 'Iron chelators for the treatment of cancer', Current Medicinal Chemistry, 19, pp. 2689 - 2702, http://dx.doi.org/10.2174/092986712800609706
    Journal articles | 2011
    Kovacevic Z; Chikhani S; Lovejoy DB; Richardson DR, 2011, 'Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: A new strategy for the treatment of pancreatic cancer', Molecular Pharmacology, 80, pp. 598 - 609, http://dx.doi.org/10.1124/mol.111.073627
    Journal articles | 2011
    Kovacevic Z; Kalinowski DS; Lovejoy DB; Yu Y; Rahmanto YS; Sharpe PC; Bernhardt PV; Richardson DR, 2011, 'The medicinal chemistry of novel iron Chelators for the treatment of cancer', Current Topics in Medicinal Chemistry, 11, pp. 483 - 499, http://dx.doi.org/10.2174/156802611794785190
    Journal articles | 2011
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR, 2011, 'The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms', Carcinogenesis, 32, pp. 732 - 740, http://dx.doi.org/10.1093/carcin/bgr046
    Journal articles | 2011
    Kovacevic Z; Yu Y; Richardson DR, 2011, 'Chelators to the rescue: Different horses for different courses!', Chemical Research in Toxicology, 24, pp. 279 - 282, http://dx.doi.org/10.1021/tx100435c
    Journal articles | 2011
    Moussa RS; Kovacevic Z; Zhang D; Siafakas AR; Richardson DR, 2011, 'Abstract A67: Mechanisms involved in regulating the expression of the cyclin-dependent kinase (cdk) inhibitor, p21, by intracellular iron levels.', Molecular Cancer Therapeutics, 10, pp. a67 - a67, http://dx.doi.org/10.1158/1535-7163.targ-11-a67
    Journal articles | 2011
    Saletta F; Kovacevic Z; Richardson DR, 2011, 'Research Spotlight: Iron chelation: Deciphering novel molecular targets for cancer therapy. the tip of the iceberg of a web of iron-regulated molecules', Future Medicinal Chemistry, 3, pp. 1983 - 1986, http://dx.doi.org/10.4155/fmc.11.154
    Journal articles | 2010
    Kovacevic Z; Kalinowski DS; Lovejoy DB; Quach P; Wong J; Richardson DR, 2010, 'Iron chelators: Development of novel compounds with high and selective anti-tumour activity', Current Drug Delivery, 7, pp. 194 - 207, http://dx.doi.org/10.2174/156720110791560991
    Journal articles | 2010
    Mrozek-Wilczkiewicz A; Kalinowski DS; Musiol R; Finster J; Szurko A; Serafin K; Knas M; Kamalapuram SK; Kovacevic Z; Jampilek J; Ratuszna A; Rzeszowska-Wolny J; Richardson DR; Polanski J, 2010, 'Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones', Bioorganic and Medicinal Chemistry, 18, pp. 2664 - 2671, http://dx.doi.org/10.1016/j.bmc.2010.02.025
    Journal articles | 2010
    Otevrel J; Mandelova Z; Pesko M; Guo J; Kralova K; Sersen F; Vejsova M; Kalinowski DS; Kovacevic Z; Coffey A; Csollei J; Richardson DR; Jampilek J, 2010, 'Investigating the spectrum of biological activity of ring- substituted salicylanilides and carbamoylphenylcarbamates', Molecules, 15, pp. 8122 - 8142, http://dx.doi.org/10.3390/molecules15118122
    Journal articles | 2009
    Assinder SJ; Dong Q; Kovacevic Z; Richardson DR, 2009, 'The TGF-β, PI3K/Akt and PTEN pathways: Established and proposed biochemical integration in prostate cancer', Biochemical Journal, 417, pp. 411 - 421, http://dx.doi.org/10.1042/BJ20081610
    Journal articles | 2009
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Richardson DR, 2009, 'Abstract B172: The metastasis suppressor NDRG1 up-regulates p21 in a p53-independent manner in cancer cells: A novel insight into its antitumor function', Molecular Cancer Therapeutics, 8, pp. b172 - b172, http://dx.doi.org/10.1158/1535-7163.targ-09-b172
    Journal articles | 2009
    Yu Y; Kalinowski DS; Kovacevic Z; Siafakas AR; Jansson PJ; Stefani C; Lovejoy DB; Sharpe PC; Bernhardt PV; Richardson DR, 2009, 'ChemInform Abstract: Thiosemicarbazones from the Old to New: Iron Chelators that Are More than Just Ribonucleotide Reductase Inhibitors', ChemInform, 40, pp. no - no, http://dx.doi.org/10.1002/chin.200950248
    Journal articles | 2009
    Yu Y; Kalinowski DS; Kovacevic Z; Siafakas AR; Jansson PJ; Stefani C; Lovejoy DB; Sharpe PC; Bernhardt PV; Richardson DR, 2009, 'Thiosemicarbazones from the old to new: Iron chelators that are more than just ribonucleotide reductase inhibitors', Journal of Medicinal Chemistry, 52, pp. 5271 - 5294, http://dx.doi.org/10.1021/jm900552r
    Journal articles | 2008
    Kovacevic Z; Fu D; Richardson DR, 2008, 'The iron-regulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets', Biochimica Et Biophysica Acta Molecular Cell Research, 1783, pp. 1981 - 1992, http://dx.doi.org/10.1016/j.bbamcr.2008.05.016
    Journal articles | 2007
    Yu Y; Kovacevic Z; Richardson DR, 2007, 'Tuning cell cycle regulation with an iron key', Cell Cycle, 6, pp. 1982 - 1994, http://dx.doi.org/10.4161/cc.6.16.4603
    Journal articles | 2006
    Kovacevic Z; Richardson DR, 2006, 'The metastasis suppressor, Ndrg-1: A new ally in the fight against cancer', Carcinogenesis, 27, pp. 2355 - 2366, http://dx.doi.org/10.1093/carcin/bgl146
  • Conference Papers | 2019
    Geleta B; Park KC; Jansson PJ; Apte M; Richardson DR; Kovacevic Z, 2019, 'Abstract A16: A novel therapeutic approach to inhibit the bidirectional oncogenic crosstalk between pancreatic cancer cells and the surrounding stroma', in Cancer Research, American Association for Cancer Research (AACR), pp. a16 - a16, http://dx.doi.org/10.1158/1538-7445.panca19-a16
    Conference Papers | 2018
    Paluncic J; Lane DJR; Saletta F; Rahmanto YS; Kovacevic Z; Richardson DR, 2018, 'Abstract B212: N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion', in Molecular Cancer Therapeutics, American Association for Cancer Research (AACR), pp. b212 - b212, http://dx.doi.org/10.1158/1535-7163.targ-17-b212
    Preprints |
    Paluncic J; Azad MG; Lane DJR; Skoda J; Park KC; Chiang S; Bae DH; Scolyer R; Afroz R; Babu G; Wilmott J; Loh K; Jansson PJ; Dharmasivam M; Huang ML; Zhao X; Kovacevic Z; Richardson DR, Melanotransferrin Functions as a Pro-Oncogenic WNT Agonist: A Yin-Yang Relationship in Melanoma with the WNT Antagonist and Metastasis Suppressor, NDRG1, http://dx.doi.org/10.1101/2023.02.27.530353

Kovacevic Z., Beheshti E.H. Unlocking the potential of cancer associated fibroblasts to defeat pancreatic cancer. NHMRC Ideas Grant (2023-2025) $637,000

Kovacevic Z., Beheshti E.H. Sahni, S. and Timpson P. Identifying metabolic changes in pancreatic fibroblasts during development of pancreatic cancer to facilitate early detection. PanKind Innovator Grant 2023 $99,077

 

2017      Recipient of a 2016 Sydney Medical School Award for Excellence for Outstanding Early Career Researcher ($1500).

2016      Awarded the NSW Premier’s Award for Outstanding Cancer Research Fellow of the Year by the Cancer Institute of NSW ($20,000).

To find out more about my team's research activities and our current projects, you can visit our website.

My Research Supervision

Mr. Jiawei Chang (Kevin) – PhD student

Mr. Shafi Alenizi – PhD student

Miss. Yujie Li – PhD student

Mr. Mekonnen Sisay – PhD student

Miss. Balquees Kanwal – visiting PhD student